Search

Querying 34 toothbrush and 92 showerhead metagenomes, researchers identified 22 complete, 232 high-quality and 362 medium-quality viral OTUs, with viral richness correlating with bacterial richness. Low sequence similarity to references and

How can we harness phage-based technologies to edit bacterial genes in the microbiome? Jesus Fernandez of Eligo Biosciences shares how they're modifying phages to base-edit mouse gut bacteria, and how that opens up new possibilities for tre

Leicester Phage is hiring a research technician to genetically engineer Salmonella-infecting bacteriophages, with the goal of developing customized phage therapeutics as alternatives to antimicrobials.

Carolin Wendling at Ludwig-Maximilians-Universität München, Munich, Germany is seeking a PhD student to work on a newly-funded European Research Council project focused on using phages to combat drug-resistant bacterial infections. They are

Alexander Harms at ETH Zurich is hiring a postdoc to study P. aeruginosa phage-host interactions, utilizing advanced genetics and genomics to uncover molecular insights that could inform phage therapy applications.

Need help with phage manufacturing, and looking for an outsourcing partner? JAFRAL manufactures phages to the highest quality and purity, and develops manufacturing processes and analytical methods for various phage types and phage applicat

This Week in Virology (TWiV) recorded a special live podcast episode at the 2024 Viruses of Microbes meeting in Cairns, Australia. Hosts Vincent Racaniello and Jolene Ramsey interviewed phage researchers Krystyna Dabrowska and Rob Lavigne a

A team at Singapore General Hospital has initiated individualized phage therapy for their first patient!

If you work with metagenomes (or metatranscriptomes), would like to explore what viruses/phages are in your datasets, but don't know where to start, the Modular Viromics Pipeline is for you!

Looking to find phage sequences in your metagenomic data? A new tool, Jaeger, finds more true positives, fewer false positives, in a reduced runtime!

William Summers has authored a new review on how the Cold War geopolitical climate in the US contributed to the decline of phage therapy, while it thrived in Eastern Europe.

Landman.Bio is a new company advancing sustainable phage-based solutions for combating bacterial infections in crops, leveraging over two decades of research from KU Leuven.

This Week in Virology (TWiV) recorded a special live podcast episode at the 2024 Viruses of Microbes meeting in Cairns, Australia. Hosts Vincent Racaniello and Jolene Ramsey interviewed phage researchers Krystyna Dabrowska and Rob Lavigne a

This month we heard about how Sartorius' columns can bring down endotoxins close to zero. There's also a new phage data resource called Phage Base! Lastly, we also picked a couple of super interesting papers this month — one about how antib

🎙️ New Podovirus Podcast Episode Alert! I had such a great time talking to Jesus Fernandez-Rodriguez, PhD, VP of Technology at Eligo Bioscience, about how they're editing live microbes in the mouse gut with engineered phages! 🧬 Highligh

The second UN General Assembly High-Level Meeting on Antimicrobial Resistance  convened yesterday to address the urgent global health crisis of AMR and its implications for public health, particularly in low- and middle-income countries.

A 75-year-old female patient with recurrent Pseudomonas septicaemia and arterial stents was treated using a phage–meropenem combination therapy at Tampere University Hospital, Finland. A 3-phage P. aeruginosa cocktail was given IV together

For OMKO1 and LPS-5, two lytic phages used in Felix Biotech’s CF trial recently, Dea M. Müller and colleagues show that determinants of their host range in P. aeruginosa are bacterial receptors, rather than anti-phage defence mechanisms.

Peiying Ho and colleagues from the Singapore-MIT Alliance for Research and Technology screened the PA14NR transposon mutant library and identified key genes involved in P. aeruginosa phage resistance. They found 78 mutants capable of thrivi

A novel phage, TS33, targeting Hafnia species in a model Brie-like cheese community; many host factors that contribute to infectivity are O-antigen genes.